精神分裂病の治療のための併用療法

Title:

精神分裂病の治療のための併用療法

Document Type and Number:

Japanese Patent JP2006505489

Kind Code:

A

Abstract:

The present invention is directed to a new treatment for schizophrenia. It has been discovered that schizophrenia will respond to the combination of an atypical antipsychotic and a valproate compound. This combination is especially useful for alleviating the acute symptoms of schizophrenia. The invention also extends to new formulations containing an antipsychotic in combination with a valproate compound.

More Like This:

JP2011084580	INHIBITION OF STRESS-INDUCED LIGAND-DEPENDENT EGFR ACTIVATION
JP2014223075	HUMANIZED ANTIBODY TO AMYLOID β
JP2017197512	NOVEL ANTIBODY-CONJUGATES WITH IMPROVED THERAPEUTIC INDEX FOR TARGETING CD30 TUMORS AND METHODS FOR IMPROVING THERAPEUTIC INDEX OF ANTIBODY-CONJUGATES

Inventors:

Somerville, Kenis D'Abrielle
Gilbert, Adrian El
Tracy, Katherine A.

Application Number:

JP2003565463A

Publication Date:

February 16, 2006

Filing Date:

January 29, 2003

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ABBOTT LABORATORIES

International Classes:

A61K45/00; A61K31/19; A61K31/38; A61K31/445; A61K31/454; A61K31/496; A61K31/519; A61K31/55; A61K31/5513; A61K31/554; A61K45/06; A61P25/18; A61P25/28

Attorney, Agent or Firm:

Yoshio Kawaguchi
Akio Ichiiri
Makoto Ono
Katsuma Osaki
Mitsuaki Tsubokura

Previous Patent: アクチン結合ペプチドを利用する髪の成長を促進する方法及び組成物

Next Patent: ゲムシタビンＨＣＶ治療のための投薬計画